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Abstract
Introduction: Influenza viruses specifically, A and B mainly contribute to seasonal outbreaks that occur globally.
However, due to limited diagnostics for influenza there is little data regarding clinical outcomes of patients with
H1N1 pneumonia in our region. Our objective was to determine the clinical characteristics and outcomes of
patients hospitalized with H1N1 pneumonia at a tertiary care facility in Karachi, Pakistan.
Methods: A retrospective study of adult patients admitted with influenza pneumonia from November 2017 to
February 2018 at a tertiary care hospital in Karachi, Pakistan. Patient characteristics were compared between
influenza A H1N1 and other types of influenza using multivariable logistic regression analysis and subgroup analysis
for factors associated with mortality in H1N1 Pneumonia was performed.
Results: Out of 497 adult patients with community acquired pneumonia (CAP), 172 fulfilled the criteria for Influenza
like illness (ILI). 88 patients had PCR confirmed Influenza pneumonia of whom n = 57 (65%) had Influenza A H1N1.
The mean age of patients 53.5 years (SD: 17.3) and 60% were male. The overall mortality from Influenza in this study
was 15.9% (n = 14); out of these 11 (78.5%) had Influenza A H1N1. Multivariable analysis showed that the increase in
length of hospital admission was significantly associated with H1N1 Influenza A infection (OR: 1.47 CI: 1.2–1.8).
Factors associated with mortality showed that presence of ARDS, Septic shock and multi-organ failure was highly
significantly associated with death (p-value < 0.001) along with deranged liver function tests (p-value 0.01) and
presence of nosocomial infection (p-value 0.027).
Conclusion: Influenza A H1N1 is associated with greater length of stay compared with infection due to other types
of Influenza and mortality in H1N1 Pneumonia was found to be associated with presence of nosocomial infection
among several other factors which may have implications given higher rates in a low-middle income country.
Keywords: Influenza, H1N1, Mortality

Background
Viral respiratory infections account for nearly 50% of
acute respiratory illness. Influenza viruses A and B cause
seasonal outbreaks with significant morbidity and mortality. The first influenza A (swine flu) virus of the
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H1N1 subtype was isolated from in humans in 1974 [1].
In 2009, the World Health Organization (WHO) announced a swine-oriented influenza virus pandemic,
H1N1 2009 pandemic [2]. During this outbreak in 2009/
2010, around 18,500 deaths were reported associated
with confirmed H1N1 influenza virus with a mortality
rate of 0.12 deaths per 100,000 populations [3]. According to United States Centers for Disease Control and
Prevention (CDC), there were 12,470 fatal cases based
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on data using mathematical models [4]. A majority of
patients with Influenza A H1N1 subtype usually present
with symptoms of upper and lower respiratory tract infections such as, sudden onset of fever, cough, sore
throat, headache, myalgia, and generalized weakness.
The symptoms may be self-limiting in most but it can
progress to severe pneumonia, acute respiratory distress
syndrome (ARDS) and mortality [5, 6]. Studies have
shown that up to 66% hospitalized patients had chest
radiographic abnormalities compatible with pneumonia
[3]. There are no unique clinical features that distinguish
Influenza A subtype H1N1 infection from other forms of
viral respiratory infections. Although a number of patients had predisposing immune-compromising conditions, healthy persons are also at risk for illness and
death from H1N1 Influenza pneumonia [2]. In a study
from Turkey; 30.6% patients presented with interstitial
infiltrates on chest radiograph and 36% with consolidation [7]. Studies have shown increased severity of disease
in pregnant women, transplant recipients and patients
with malignancies [8, 9]. There have been conflicting
data from different parts of the world with some regions
reporting better survival in ventilated patients [10] and
some regions with poor outcomes in patients requiring
intensive care [11].
Influenza A H1N1 has been reported globally but
there is limited data available from Pakistan. In 2009, a
single center case series reported 36 confirmed H1N1
cases with 16.7% mortality from in Pakistan [12]. Most
of these cases were previously healthy individuals who
developed an influenza-like illness that progressed to
pneumonia within 5 to 7 days (5).
Despite yearly outbreaks each winter; data available
from Pakistan on clinical characteristics and outcomes
of H1N1 pneumonia patients is scarce [12, 13] and none
is available from recent outbreaks. The aim of the study
was to determine the clinical characteristics, course of
disease and outcomes of these patients when hospitalized with H1N1 pneumonia in tertiary care hospital.

Methods
Ethical approval

This study received approval from the Ethical Review
Committee of the hospital (5277-Med-ERC-18). The
data was collected from hospital records and the requirement for informed consent was waived by the hospital ethical review committee as data was anonymized
and no personal identifiers were collected.
Study population and design

We conducted a retrospective descriptive study of adult
patients admitted with a diagnosis of Influenza pneumonia from November 2017 to February 2018 at a 700 bedded tertiary care hospital in Karachi, Pakistan. All
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patients admitted with the diagnosis of community acquired pneumonia during the study period were identified from the hospital information management system.
Influenza-like illness (ILI) was defined as “An acute respiratory illness with a measured temperature of ≥38 °C
and cough, with onset within the past 10 days” [14]. A
confirmed case of influenza pneumonia was defined as
an individual with an ILI with laboratory-confirmed influenza by Influenza virus PCR assay in respiratory
specimen.
Demographic and clinical characteristics of confirmed
influenza patients including, underlying medical and respiratory co-morbidities and laboratory and radiological
investigations, treatment and complications during
hospitalization were collected on a structured performa
from hospital medical records.
Diagnosis of influenza

Nasopharyngeal swabs were processed for detection of
Influenza virus by real-time reverse transcriptase polymerase chain reaction (RT-PCR) using the Influenza
virus PCR assay (Altona Diagnostics, GmbH).
Radiological diagnosis of pneumonia was made by
evaluation of infiltrates observed on chest X ray and/or
CT chest scans. A multidisciplinary team of doctors including infectious diseases consultants, pulmonologists
and intensivits were involved in identification of cases
and their management.
Data analysis

STATA ver 12.1was used for data analysis. Descriptive
analysis was performed for demographic features with
mean and standard deviation reported for quantitative
variables such as age and lengths of hospital stay and
frequencies (percentage) for qualitative variables such as
gender, co-morbid conditions, mortality and complications etc. χ2 test of independence or Fischer Exact test
was performed for comparison of factors between those
with H1N1 Influenza compared to those with Influenza
other than H1N1 subtype. Multivariable logistic regression analysis was performed on variables found to be significant on univariate analysis to identify factors
associated with Influenza A H1N1 infection. All p value
≤0.05 was taken as significant. Subgroup analysis was
also done using χ2 test of independence or Fischer Exact
test for comparison between those who died compared
to those who recovered from H1N1 Influenza.

Results
Total of 497 patients of age 18 years and above were admitted during this period with community acquired
pneumonia (CAP) out of which 172 fulfilled the criteria
for Influenza like illness (ILI). Out of 172 patients admitted with ILI, 88 (51%) patients fulfilled the criteria of
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confirmed Influenza pneumonia. Majority of the patients
had Influenza A H1N1 (n = 57) 65% while, (n = 6) 7% patients had non H1N1 Influenza A and (n = 25) 28% patients had Influenza B.
The mean age of patients with H1N1 Influenza was
53.5 years (SD: 17.3). Thirty-four patients (59.6%) were
female and six of them were pregnant. Hypertension was
the commonest co-morbid condition as found in 44% of
H1N1 cases. Sixty-three percent of the Influenza A
H1N1 patients were non-smokers. Only three (5.2%) patients had received quadrivalent inactivated influenza
vaccination.
Risk factors associated with influenza were evaluated
in patients with H1N1 influenza. None of the cases had
a recent history of travel outside of the country or, had
occupational exposure to livestock. Only one was a
health care provider. The median duration of illness
prior to presentation of Influenza was 5 days (IQR: 2)
(Table 1). Amongst Influenza A H1N1 patients, 96% patient had interstitial infiltrates on chest radiography and
the most frequently associated lung condition was
Chronic Obstructive Pulmonary disease (COPD) (n = 8).
Of patients with Influenza A H1N1 subtype, microbiological cultures of respiratory secretions taken on admission were tested in 23 cases and were found to be

positive in 6 (26%) patients. Three patients had a polymicrobial growth of Staphylococcus aureus and Aspergillus species (two had A. flavus and one had A. fumigatus)
and three patients had isolated growth of Aspergillus flavus. All patients with H1N1 influenza received Oseltamivir as well as antibiotics empirically.
The clinical outcomes of patients with Influenza A
H1N1 infection are summarized in Table 2. The mean
length of stay was 8 days (SD: 6). The overall mortality
from Influenza virus infection during this period was
15.9% (14/88). Eleven (78.5%) of 14 patients who died
were positive for Influenza A H1N1 subtype. Further,
the mortality in Influenza A subtype H1N1 pneumonia
was 19% (11/57).
The laboratory parameters including mean white
blood cell count, creatinine and blood glucose levels
were similar for both patients with H1N1 and influenza
other than H1N1 with the exception of transaminase
levels (SGPT and SGOT) which had a higher trend in
patients infected with Influenza A subtype H1N1 pneumonia (Supplementary Table 1).
Amongst patients with H1N1, nineteen (33.3%) required ICU admission and mechanical ventilation whilst
none of the other cases (with influenza A non-H1N1 or
Influenza B), p-value: 0.001. The mean duration of

Table 1 Baseline characteristics of patients with Influenza subtype H1N1 compared to other than H1N1 during the outbreak of 2017
Characteristic

H1N1 (N = 57)

Other than H1N1 (N = 31)

p-value

Mean Age ± SD

53.5 ± 17.3

61.3 ± 12.6

0.035

Mean CURB score ± SD

1.9 ± 0.98

1.5 ± 0.99

0.091

Median Duration Of Illness (Range)

5 (2–10)

4 (2–7)

0.636

Male

23

15

Female

34

16

Pregnant

6

0

7

4

Gender

0.467

Smoking status
Current Smoker

0.001
1.000

Ex-Smoker

11

6

Non Smoker

36

20

Don’t know

3

1

Diabetes

24

12

0.757

Hypertension

25

18

0.203

COPD

8

4

Cardiac Problems

13

3

Obesity

5

1

CVA

2

0

Co-morbids

Malignancy

2

1

Immunosuppression

7

2

Abbreviations: COPD Chronic Obstructive Pulmonary disease; CVA Cerebrovascular Accident
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Table 2 Outcomes and Complications of patients with Influenza subtype H1N1 compared to other than H1N1 during the outbreak
of 2017
Variables

H1N1 (N = 57)

Other than H1N1 (N = 31)

p-value

19

0

0.001

Type of admission
ICU
SCU

28

17

0.968

Ward

10

13

0.013

13

1

0.016

Management
Vasopressors
Non-invasive ventilation

20

9

0.564

Invasive Ventilation

19

0

< 0.001

Mean Duration Of Intubation ± SD

3.06 ± 4.97

0

Systemic Steroids

23

11

0.654

Antibiotics

56

29

0.282

Oseltamivir

57

28

0.041

Respiratory Failure

34

9

0.009

ARDS

18

0

< 0.001

Septic Shock

14

1

0.015

MODS

13

3

0.157

Nosocomial Infection

7

0

0.049

Acute Kidney Injury

24

6

0.032

NSTEMI

9

2

0.315

42

26

Complications

Outcome
Recovered

0.359

Dead

11

3

Unknown

4

2

Median Length Of Stay (Range)

6 (1–25)

3 (0–12)

0.001

Abbreviations: ICU Intensive care unit; SCU Special care unit; ARDS Acute Respiratory Distress Syndrome; MODS Multi-organ dysfunction Syndrome; NSTEMI Non- ST
elevation myocardial infarction

intubation was 3.06 days (SD: 4.97) among 19 patients,
who required mechanical ventilation. This was significantly different when compared to patients who had influenza other than H1N1 as none of patients in that
group required mechanical ventilation. The mortality
among mechanically ventilated patient were 47.3% (n =
9/19). Twenty nine (33%) patients required non-invasive
ventilation (NIV). Twenty of 29 patients who required
NIV had H1N1 pneumonia. Five patients who required
NIV died and the association was not statistically significant (p = 0.7); 4 of these patients had H1N1 pneumonia.
The hospital course was complicated by nosocomial
pneumonia in 8 (14%) of those with H1N1 influenza
compared to none in the other group (p-value: 0.046)
(Table 2). Patients were diagnosed to have superimposed
infection based on culture and sensitivity results of sputum or bronchoscopy specimens obtained during course
of hospital stay. Acinetobacter species was isolated in 5
patients and Pseudomonas aeruginosa was isolated in 3

patients. Aspergillus species were identified from sputum
specimens of 8 patients, 6 at the time of admission and
2 during the course of hospital stay. Aspergillus flavus
was the predominant species in 6 out of 8 specimens. 4
patients in whom Aspergillus species had been isolated
had H1N1 pneumonia, one had Influenza A non- H1N1
and remaining had Influenza B pneumonia. None of
these patients required ICU admission and only one patient died.
Associated factors with H1N1 Influenza A compared
to other Influenza types were assessed using univariate
and multivariate analysis. In univariate analysis, presence
of ARDS and invasive ventilation were found to be
highly significant (p = value < 0.001). Other significant
risk factors included intensive care unit admission (pvalue: 0.001), septic shock (p-value: 0.015), respiratory
failure (p-value: 0.009) and increase in length of stay (pvalue: 0.001). However in the multivariable analysis, only
increase in length of stay was significantly associated
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with H1N1 Influenza infection (OR:1.47 CI: 1.2–1.8) and
increase in age was found to be protective for H1N1 infection (OR:0.93 CI: 0.89–0.97) suggesting that H1N1
may be more predominantly affecting relatively younger
age groups after adjusting for confounding.
Subgroup analysis for factors associated with mortality
in H1N1 influenza was done using Fischer Exact test
and it was found that presence of ARDS, Septic shock
and multi-organ failure was highly significantly associated with death (p-value < 0.001) along with deranged
liver function tests (p-value 0.01) and presence of nosocomial infection(p-value 0.027) (Table 3).

Discussion
The World Health Organization (WHO) declared Influenza
H1N1virus to have transitioned into post-pandemic period
but with the potential to cause outbreaks in 2010. WHO
Surveillance reports from December 2017 showed predominant circulation of influenza A(H1N1)pdm09 virus with influenza A(H3N2) in Pakistan. Our study is the first from
the country to describe the clinical characteristics and outcomes of patients affected with Influenza in that period. As
per CDC, Influenza season between 2017 and 2018 was of
high severity with multiple people visiting emergencies as
well outpatient clinics with Influenza like illness and deaths
due to pneumonia and influenza were reported to be approximately 10% nationally across the United States with
predominant circulating strain being Influenza A(H3N2)
[15]. As opposed to this, in Europe, the majority of cases
were due to influenza virus type B infection with excess
mortality from all causes as per European Centre for
Disease Prevention. However, from South Asia including,
Afghanistan and India, the predominant strain was H1N1
[16]. In a single center study from India, the mortality was
29% but it did not include cases from the 2017 outbreak. In
our study, overall mortality from Influenza was 15.9% and
mortality from H1N1 subtype was 19%. Study from
Pakistan sentinel sites reported 11% mortality from H1N1
in 2009 [13] and 16% in another single center study [12].
Mean age in our cohort was 55 years as opposed to 36 years
during the 2009 Influenza outbreak in Pakistan [13].

However gender distribution also reflected similar predilection for females [12]. Among the risk factors, we did not
find significant association with smoking or obesity as
reported from other studies [17, 18] and majority of our
patients were non-smokers as opposed to another study
from Pakistan [13]. Eighteen percent required ICU admission as compared to 27% in another study done during the
2009 pandemic [12].
Secondary bacterial pneumonia is a well-recognized
complication of influenza and most commonly implicated
organisms include Staphylococcus aureus Streptococcus
pneumonia and Klebsiella sp. [19]. In our study we found
Aspergillus species in 6 out of 23 sputum specimens sent
at admission with 3 having concomitant Staphylococcus
aureus. S. aureus has been reported to cause superimposed infection in patients with H1N1 influenza [20, 21].
However, Aspergillus species have recently been reported
to complicate severe influenza infections [22]. Influenza
associated Aspergillosis (IAA) has been reported to occur
in immunocompetent patients with Influenza and a large
multicenter study from Netherlands reported 16% IAA in
their cohort. They also concluded that approximately all
cases that have been reported so far are associated with influenza A H1N1 infection [23]. However, the limitation of
our study is that we could not differentiate colonization
with Aspergillus from Influenza associated Aspergillosis.
Moreover our study has limited generalizability as it’s a
single center study. Findings from this study have implications for management in developing countries where the
burden of multi-drug resistant healthcare associated infections and invasive fungal infections is high [24, 25] and
may adversely affect outcomes in Influenza A H1N1 pneumonia since mortality is greater in patient who developed
nosocomial infections.

Conclusion
Influenza A H1N1 is associated with greater length of
stay compared with infection due to other types of Influenza and mortality in H1N1 Pneumonia was found to be
associated with presence of nosocomial infection among
several other factors which may have implications given
higher rates in a low-middle income country.

Table 3 Subgroup analysis for mortality in H1N1 pneumonia
Variables

Died (n = 11)

Recovered (n = 42)

p-value

Supplementary information

Invasive ventilation

9

9

< 0.001

Supplementary information accompanies this paper at https://doi.org/10.
1186/s41479-020-00070-7.

Respiratory failure

10

20

0.001

ARDS

10

7

< 0.001

Septic Shock

10

4

< 0.001

MODS

9

2

< 0.001

Nosocomial Infection

4

3

0.027

Transaminitis

7

6

0.010

Abbreviations: ARDS Acute Respiratory Distress Syndrome; MODS Multi-organ
dysfunction Syndrome

Additional file 1: Supplementary Table 1. Laboratory Data for H1N1
pneumonia patients compared to Influenza other than H1N1.
Abbreviations: WBC: White blood cell count; CRP: C-reactive protein; SGPT:
Serum glutamic pyruvic transaminase.
Abbreviations
WHO: World Health Organization; CDC: Centers for Disease Control and
Prevention; ARDS: Acute respiratory distress syndrome; ERC: Ethical Review
Committee; ILI: Influenza-like illness; RT-PCR: Real-time reverse transcriptase
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polymerase chain reaction; CAP: Community acquired pneumonia;
COPD: Chronic Obstructive Pulmonary disease; SGPT: Serum glutamic pyruvic
transaminase; SGOT: Serum glutamic-oxaloacetic transaminase; ICU: Intensive
care unit; NIV: Non-invasive ventilation; IAA: Influenza associated aspergillosis
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